The biggest challenge in the Pharmaceutical industry is fighting

corruption

El mayor desafío contra la industria farmacéutica es la lucha contra la

corrupción

PRO

According to FINANCE WORL WIDE many of the people who are part of the government have the
power to decide and manage the situation behind the agreements in their favor, it turns out that
they are investors in these pharmaceutical companies, and they take advantage of their power
over small companies, which don’t earn the same as a pharmaceutical company with more time in
the market. Also Patents are created and the medicines are on sale for many years, this is where
corruption comes in, they work with these companies, they control prices and since they are
unique, investors manipulate through marketing and medicines are distributed to hospitals or
clinics, and many doctors prescribe those medicines that are not affordable for many people,
benefiting some laboratories. A monopoly is created by these people with power, harming the
public sector and people who cannot acquire this medicines for economic reasons.

So basically, Well-founded medicine patents are used excessively and without real restrictions,
lead to the establishment of monopolies that determine the high prices of the product. This high
cost is one of The main factors that determine the difficulties in accessing medicines in developing
countries.

AGAINST

because there are now generic medicines that contain the same properties as other medicines and
these can be produced and once the patent of the brand-name medicine has expired, small
pharmaceutical companies can compete legally. According to world health organization. the
ministry of health is in charge of regulation and control; taking the necessary measures to comply
with what has been agreed. Is one of the most effective way to generate fair competition that
leads to price reduction. Understood as the main determinant of the lack of access to medicines.
So all approved medications by the Ministry of Health, must go through the same quality controls,
safety and efficacy. Generic medicines are only made available after rigorous review by the FDA
food and drug administration. In addition, doctors have to offer medicines impartially, without
benefiting any laboratory in particular, giving the patient the option to choose.

I UNDERSTAND WHAT YOU MEAN

Refuter a alguien que esta en contra

most of these companies take advantage of the situation to raise prices and they are not willing to
lower the price, investors always want to earn more than 100 or 200 percent. unfortunately, the
misuse of the budget and the bribery in the health sector, has a negative impact on the economic
side, making it difficult to finance hospital or clinics and have better quality of care.
Wait for an agreement to be reached between the government and the companies, how many
months or years have to pass. while doctors continue to work with these medicines and people
continue to buy.

Quien esta a favor

but before these companies enter the market they are investigated and evaluated by the FDA food
and drug administration, once the product is marketed, new clinical trials are carried out, to
determine its effectiveness for other indications, reformulate the drug to improve it or continue
collecting information about adverse effects. So the authorities can bet on a medicine under
evaluation, taking into account that it is in favor of the people, they would run a great risk if they
do so.